ATE355082T1 - POURABLE LIQUID CARRIER CONTAINING POLYOXYALKYLENE BLOCK COPOLYMERS - Google Patents

POURABLE LIQUID CARRIER CONTAINING POLYOXYALKYLENE BLOCK COPOLYMERS

Info

Publication number
ATE355082T1
ATE355082T1 AT00960062T AT00960062T ATE355082T1 AT E355082 T1 ATE355082 T1 AT E355082T1 AT 00960062 T AT00960062 T AT 00960062T AT 00960062 T AT00960062 T AT 00960062T AT E355082 T1 ATE355082 T1 AT E355082T1
Authority
AT
Austria
Prior art keywords
pourable liquid
block copolymers
liquid carrier
carrier containing
compositions
Prior art date
Application number
AT00960062T
Other languages
German (de)
Inventor
Douglas Joseph Dobrozsi
Jerry William Ii Hayes
Bjorn Olof Lindman
Rouja Hristova Ivanova
Paschalis Alexandridis
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE355082T1 publication Critical patent/ATE355082T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Lubricants (AREA)
  • Detergent Compositions (AREA)
  • Polyethers (AREA)

Abstract

The present invention covers pourable liquid vehicles that can be combined with compositions, materials and substances. Among the benefits of such pourable liquid vehicles is the compositions are retained on the moistened surface for a period of time sufficient to allow compositions, materials and substances to act on said surface, resisting erosion or run-off from additional moisture being applied. Such pourable liquid vehicles have a number of utilities including but not limited to cleaning and treating surfaces of objects as well as biological or living organisms, including living creatures.
AT00960062T 1999-09-11 2000-09-11 POURABLE LIQUID CARRIER CONTAINING POLYOXYALKYLENE BLOCK COPOLYMERS ATE355082T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15326099P 1999-09-11 1999-09-11

Publications (1)

Publication Number Publication Date
ATE355082T1 true ATE355082T1 (en) 2006-03-15

Family

ID=22546438

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00960062T ATE355082T1 (en) 1999-09-11 2000-09-11 POURABLE LIQUID CARRIER CONTAINING POLYOXYALKYLENE BLOCK COPOLYMERS

Country Status (12)

Country Link
US (1) US6503955B1 (en)
EP (1) EP1212091B1 (en)
JP (1) JP2003509350A (en)
CN (1) CN1373674A (en)
AT (1) ATE355082T1 (en)
AU (1) AU770516B2 (en)
CA (1) CA2383570C (en)
DE (1) DE60033671T2 (en)
ES (1) ES2282134T3 (en)
MX (1) MXPA02002607A (en)
TR (1) TR200200616T2 (en)
WO (1) WO2001019329A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE285821T1 (en) * 1999-10-08 2005-01-15 Affinium Pharm Inc FAB I INHIBITORS
CA2419147C (en) * 2000-08-25 2008-10-07 Kowa Company, Ltd. Fill liquid composition for ibuprofen capsule and capsule preparation
JP4822652B2 (en) * 2000-11-22 2011-11-24 エンド ファーマシューティカルズ インコーポレイテッド Treatment of mucositis
JP4387804B2 (en) * 2001-04-06 2009-12-24 アフィニアム・ファーマシューティカルズ・インコーポレイテッド FabI inhibitor
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
FR2838349B1 (en) * 2002-04-15 2004-06-25 Laurence Paris LIQUID COMPOSITIONS FOR SUSTAINED RELEASE SOFT CAPSULES AND PROCESS FOR PRODUCING THE SAME
EP1575951B1 (en) 2002-12-06 2014-06-25 Debiopharm International SA Heterocyclic compounds, methods of making them and their use in therapy
US20060140985A1 (en) * 2003-01-10 2006-06-29 Zhong Zhang Lansoprazole formulations and related processes and methods
EP1608377B1 (en) 2003-03-17 2008-10-01 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
JP2006008696A (en) * 2003-03-20 2006-01-12 Mitsubishi Pharma Corp Pharmaceutical preparation containing arginine amides
WO2004090613A1 (en) * 2003-04-03 2004-10-21 Seed Co., Ltd. Ophthalmic lenses capable of sustained drug release and preservative solutions therefor
US20050118261A1 (en) * 2003-06-12 2005-06-02 Oien Hal J. Compositions and methods of administering doxepin to mucosal tissue
JP2007513952A (en) * 2003-12-11 2007-05-31 アルコン、インコーポレイテッド Ophthalmic composition comprising a polysaccharide / borate gelling system
ES2515101T3 (en) * 2004-06-04 2014-10-29 Debiopharm International Sa Acrylamide derivatives as antibiotic agents
CN1311873C (en) * 2004-06-30 2007-04-25 上海复康医药科技发展有限公司 Temperature sensitive gel formulation for in situ vagina uses
US7947508B2 (en) * 2004-11-30 2011-05-24 Align Technology, Inc. Systems and methods for intra-oral diagnosis
US7766658B2 (en) * 2004-11-30 2010-08-03 Align Technology, Inc. Systems and methods for intra-oral diagnosis
US20060115782A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for coating a dental appliance
US20060115785A1 (en) 2004-11-30 2006-06-01 Chunhua Li Systems and methods for intra-oral drug delivery
WO2006091719A2 (en) * 2005-02-23 2006-08-31 Sontra Medical Corporation Compositions and methods enhancing transdermal delivery of drugs and biologics
EP1965787B1 (en) * 2005-11-30 2013-04-10 Endo Pharmaceuticals Inc. Treatment of xerostomia with a sulfur-containing antioxidant
CA2632476A1 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
US20070196329A1 (en) * 2006-01-20 2007-08-23 Erning Xia Disinfection efficacy of lens care regimen for rigid gas permeable contact lenses
CN101400337A (en) * 2006-03-10 2009-04-01 拉伯斯威斯股份有限公司 Method for solubilizing, dispersing, and stabilizing materials, products manufactured according to said method, and use thereof
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
BR112013024794A2 (en) * 2011-04-01 2018-07-10 Univ Florida thermosensitive, mucoadhesive or dermoadhesive formulations, and penetration enhancement for topical therapeutic release
ITFI20110241A1 (en) * 2011-11-03 2013-05-04 Lo Li Pharma Srl FORMULATIONS TO IMPROVE THE PROBABILITY OF FECONDATION AND THE NUMBER OF PREGNANCIES
UA113215C2 (en) 2012-06-19 2016-12-26 (E) -N-METHYL-N - (((3-METHYLBENZOFURAN-2-IL) METHYL) DERIVATIVES IL) ACRYLAMIDE
UY36570A (en) * 2015-02-26 2016-10-31 Merial Inc INJECTABLE FORMULATIONS OF PROLONGED ACTION THAT INCLUDE AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES OF THE SAME
MA43697B1 (en) 2016-02-26 2021-01-29 Debiopharm Int Sa Medicine for the treatment of diabetic foot infections
AU2018216886B2 (en) 2017-02-01 2023-02-23 Johnson & Johnson Consumer Inc. A lozenge

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188373A (en) 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4100271A (en) 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4474752A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4478822A (en) 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4511563A (en) 1983-07-15 1985-04-16 Basf Wyandotte Corporation Clear analgesic gels with reduced tackiness
PT83095B (en) 1985-07-30 1987-12-23 Int Minerals & Chem Corp Method for the stabilization of growth promoting hormones using polyoxyethylene-polyoxypropylene copolymers
DE3532562A1 (en) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg TRANSDERMALLY RESORBABLE, WATER-BASED PREPARATIONS OF ARYLPROPIONIC ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
US5030448A (en) 1986-05-15 1991-07-09 Emory University Method of delivering drugs to damaged or diseased tissue
US4810503A (en) 1987-03-31 1989-03-07 Basf Corporation Polymers which form gels at low concentrations in water
US5135751A (en) 1988-11-16 1992-08-04 Mediventures Incorporated Composition for reducing postsurgical adhesions
US5681576A (en) * 1988-11-16 1997-10-28 Mdv Technologies, Inc. Method and composition for post surgical adhesion reduction
US4911926A (en) 1988-11-16 1990-03-27 Mediventures Inc. Method and composition for reducing postsurgical adhesions
US5256396A (en) 1990-01-24 1993-10-26 Colgate-Palmolive Company Topical composition
US5300295A (en) 1990-05-01 1994-04-05 Mediventures, Inc. Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH
US5292516A (en) 1990-05-01 1994-03-08 Mediventures, Inc. Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers
US5298260A (en) 1990-05-01 1994-03-29 Mediventures, Inc. Topical drug delivery with polyoxyalkylene polymer thermoreversible gels adjustable for pH and osmolality
US5306501A (en) 1990-05-01 1994-04-26 Mediventures, Inc. Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers
US5346703A (en) 1990-08-07 1994-09-13 Mediventures, Inc. Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5143731A (en) 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5071644A (en) 1990-08-07 1991-12-10 Mediventures, Inc. Topical drug delivery with thermo-irreversible gels
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
CN1106259A (en) 1994-02-05 1995-08-09 日东制药株式会社 Antiphlogistic and analgesic gel agent for external use containing propanoic acid non steroid pharmaceutical as effective composition
AU1332997A (en) 1995-12-11 1997-07-03 Mdv Technologies, Inc. Ophthalmic composition comprising polyoxyethylene-polyoxypropylene polymers

Also Published As

Publication number Publication date
CA2383570C (en) 2008-08-12
ES2282134T3 (en) 2007-10-16
JP2003509350A (en) 2003-03-11
CA2383570A1 (en) 2001-03-22
EP1212091A2 (en) 2002-06-12
CN1373674A (en) 2002-10-09
TR200200616T2 (en) 2002-06-21
WO2001019329A2 (en) 2001-03-22
AU770516B2 (en) 2004-02-26
WO2001019329A3 (en) 2001-08-02
MXPA02002607A (en) 2002-07-30
EP1212091B1 (en) 2007-02-28
AU7128200A (en) 2001-04-17
DE60033671T2 (en) 2007-12-06
DE60033671D1 (en) 2007-04-12
US6503955B1 (en) 2003-01-07

Similar Documents

Publication Publication Date Title
ATE355082T1 (en) POURABLE LIQUID CARRIER CONTAINING POLYOXYALKYLENE BLOCK COPOLYMERS
DE69934229D1 (en) COMPOSITION FOR THE DEALING OF PHOTOLACK AND ORGANIC MATERIALS OF SUBSTRATE SURFACES
DE69728594D1 (en) Chromium-free composition for the treatment of metal surfaces
DE69840898D1 (en) BIOSTATIVE COATINGS TO REDUCE AND PREVENT BACTERIAL APPLICATIONS
DE60043229D1 (en) COMPOSITION FOR VESSEL COATING
PL365182A1 (en) Water-soluble or water-swellable, associatively thickening copolymers containing sulfo groups, method for producing the same and use thereof
ATE284953T1 (en) COMPOSITION FOR REDUCING BAD ODORS CONTAINING A LACCASE
BR9808660A (en) Detergent composition for use with a cleaning utensil containing superabsorbent material and kits containing both.
MX9502240A (en) Passification of optically variable pigment and waterborne coating compositions containing the same.
BR9304988A (en) Self-dispersing compositions in water containing organopolysiloxane and process for wood treatment
DE69528484D1 (en) Layer for the distribution of liquid in absorbent articles
BR9407526A (en) Dishwashing detergent composition in gel or concentrated liquid containing calcium xylene sulfonate
ATE291897T1 (en) USE OF COMPOSITIONS CONTAINING STABILIZED ENZYMES
BR9401459A (en) Liquid cleaning composition, and, process for treating soiled materials with stains to loosen or remove them
DE10082139T1 (en) Composition for the treatment of friction pairs
DE69918933D1 (en) INHIBITION OF DEGRADATION MEDIATED BY SULFATE-REDUCING BACTERIA BY USE OF BACTERIA THAT EXHAUST ANTI-MICROCROBIAL SUBSTANCES
DE69941821D1 (en) FLUORENT HARDENING COMPOSITION FOR TREATING SURFACES
WO2002034815A3 (en) Compositions and methods for treating surfaces
DE69111768D1 (en) Enzymatic composition for the determination of ethanol.
GB9819397D0 (en) Composition for the removal of biological and organic substances
WO2000038617A3 (en) Compositions and methods of using the same
AR017402A1 (en) A WHITENING COMPOSITION TO ELIMINATE SUBSTRATE SPOTS, A METHOD FOR WHITENING A SPOTTED SUBSTRATE AND A METHOD TO INHIBIT DEVELOPLOMICROBIAL DEVELOPMENT IN FLEXIBLE OR HARD SURFACE SUBSTRATES
DE3778158D1 (en) INHIBITORS OF ESTERASE-PRODUCING MICRO-ORGANISMS FOR MAIN USE IN DEODORANTS.
MX9706354A (en) Aqueous polish compositions containing acid-amine latexes.
MA24255A1 (en) NON-BODY LIQUID DETERGENT COMPOSITIONS CONTAINING PARTICLES OF ENZYMES HAVING REDUCED SIZE.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties